1. Wnt Signaling in Cancer Stem Cell Biology
   Felipe de Sousa e Melo et al, 2016, Cancers CrossRef
2. null
   Yann Duchartre et al, 2017 CrossRef
3. Concise Review: Emerging Drugs Targeting Epithelial Cancer Stem-Like Cells
   Mehreen Ahmed et al, 2017, Stem Cells CrossRef
4. Targeting autophagy in cancer stem cells as an anticancer therapy
   Yuanyuan Lei et al, 2017, Cancer Letters CrossRef
5. GSK-3β inhibitor 6-bromo-indirubin-3′-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells
   Kunping Liu et al, 2017 CrossRef
6. Dishevelled 1, a pivotal positive regulator of the Wnt signalling pathway, mediates 5-fluorouracil resistance in HepG2 cells
   Yisong Xu et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
7. Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116
   Egle Kukcinaviciute et al, 2018, J. Cell. Biochem. CrossRef
8. A DNA-Encoded Library of Chemical Compounds Based on Common Scaffolding Structures Reveals the Impact of Ligand Geometry on Protein Recognition
   Nicholas Favalli et al, 2018, ChemMedChem CrossRef
9. Quantitative Proteomic Analysis of 2D and 3D Cultured Colorectal Cancer Cells: Profiling of Tankyrase Inhibitor XAV939-Induced Proteome
   Young Eun Kim et al, 2018, Sci Rep CrossRef
10. XAV939, a Wnt/β-catenin pathway modulator, has inhibitory effects on LPS-induced inflammatory response
    Jaewoong Jang et al, 2018, Immunopharmacology and Immunotoxicology CrossRef
11. null
    Cristina Albuquerque et al, 2018 CrossRef
12. Tankyrase: Function and Tankyrase Inhibitor in Cancer
    Mi Kyung Kim, 2018, BSL CrossRef
13. HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma
    Yu Wu et al, 2019, Chemico-Biological Interactions CrossRef
14. WNT Signaling in Cardiac and Vascular Disease
    Sébastien Foulquier et al, 2018, Pharmacol Rev CrossRef
15. Investigating the regulation mechanism of baicalin on triple negative breast cancer’s biological network by a systematic biological strategy
    Kailin Yang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
16. Inhibition of WNT signaling reduces differentiation and induces sensitivity to doxorubicin in human malignant neuroblastoma SH-SY5Y cells
    Junjira Suebsoonthron et al, 2017, Anti-Cancer Drugs CrossRef
17. Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention
    Claudia Gasch et al, 2017, Mol Cancer CrossRef
18. WNT Signaling and Colorectal Cancer
    Emma M. Schatoff et al, 2017, Curr Colorectal Cancer Rep CrossRef
19. Targeting Tankyrase to Fight WNT-dependent Tumours
    Tor Espen Thorvaldsen, 2017, Basic Clin Pharmacol Toxicol CrossRef
20. Macrophages as an Emerging Source of Wnt Ligands: Relevance in Mucosal Integrity
    Jesús Cosin-Roger et al, 2019, Front. Immunol. CrossRef
21. Poly(ADP-ribose) polymerase enzymes and the maintenance of genome integrity
    Travis Eisemann et al, 2019, Cell. Mol. Life Sci. CrossRef
22. Downregulation of CXXC Finger Protein 4 Leads to a Tamoxifen-resistant Phenotype in Breast Cancer Cells Through Activation of the Wnt/β-catenin Pathway
    Yijie Fu et al, 2020, Translational Oncology CrossRef
23. Wnt-β-catenin Signaling Pathway, the Achilles' Heels of Cancer Multidrug Resistance
    Morteza Ghandadi et al, 2019, CPD CrossRef
24. Inhibition of Wnt signalling pathway by XAV939 enhances radiosensitivity in human cervical cancer HeLa cells
    Jinhua Zhang et al, 2020, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
25. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance
    Feng Luo et al, 2016, Oncotarget CrossRef
26. Emerging agents that target signaling pathways in cancer stem cells
    Yue Yang et al, 2020, J Hematol Oncol CrossRef
27. Regulation of poly ADP-ribosylation of VEGF by an interplay between PARP-16 and TNKS-2
    Haritha Kunhiraman et al, 2020, Mol Cell Biochem CrossRef
28. Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer (Review)
    Emiko Niiro et al, 2018, biom rep CrossRef
29. DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway
    Feng Jin et al, 2020, Int J Oncol CrossRef
30. Novel insight into the function of tankyrase (Review)
    Mi Kim, 2018, Oncol Lett CrossRef
31. Anticancer effect of XAV939 is observed by inhibiting lactose dehydrogenase A in a 3‑dimensional culture of colorectal cancer cells
    Dahee Kim et al, 2019, Oncol Lett CrossRef
32. Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer
    Till Kaltofen et al, 2020, J Cancer Res Clin Oncol CrossRef
33. 3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors
    Luned M. Badder et al, 2020, PLoS ONE CrossRef
34. Bioinformatic analysis reveals the molecular targets of tangeretin in overcoming the resistance of breast cancer to tamoxifen
    Adam Hermawan et al, 2020, Gene Reports CrossRef
35. Shorter telomere length, higher telomerase activity in association with tankyrase gene polymorphism contribute to high-altitude pulmonary edema
    Manjula Miglani et al, 2020 CrossRef
36. Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks
    Monica Sharma et al, 2020, IJMS CrossRef
37. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Ya Zhang et al, 2020, J Hematol Oncol CrossRef
38. Distinct Colorectal Cancer–Associated APC Mutations Dictate Response to Tankyrase Inhibition
    Emma M. Schatoff et al, 2019, Cancer Discov CrossRef
39. Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/β-catenin-signaling pathway
    Sirorut Sinnung et al, 2021, Mol Cell Biochem CrossRef
40. Emerging Strategies for Sensitization of Therapy Resistant Tumors Toward Cancer Therapeutics by Targeting the Bcl-2 Family, TGF-β, Wnt/β-Catenin, RASSF and miRNA Regulated Signaling Pathways
    Veerasamy Tarmarajen et al, 2021, The International Journal of Biochemistry & Cell Biology CrossRef
41. Seeding drug discovery: Telomeric tankyrase as a pharmacological target for the pathophysiology of high-altitude hypoxia
    Manjula Miglani et al, 2021, Drug Discovery Today CrossRef
42. Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma
    Jianjia Xiao et al, 2021, Bioengineered CrossRef
43. The Small Molecule BC-2059 Inhibits Wingless/Integrated (Wnt)-Dependent Gene Transcription in Cancer through Disruption of the Transducin β-Like 1-β-Catenin Protein Complex
    Raffaella Soldi et al, 2021, J Pharmacol Exp Ther CrossRef
44. The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy
    Zhuo Wang et al, 2021, Biomark Res CrossRef
45. null
    Evangelos P. Daskalopoulos et al, 2021 CrossRef
46. Therapeutic Potential of Naturally Occurring Small Molecules to Target the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer
    Luiz F. S. Oliveira et al, 2022, Cancers CrossRef